Lipoprotein(a): A Genetically Determined, Causal, and Prevalent

Lipoprotein (a) CME Continuing Medical Education

Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease

What Is Lipoprotein(a) and Its Connection to Heart Disease? - GoodRx

Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction - ScienceDirect

Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies - Alhomoud - 2023 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library

LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study: Molecular Therapy - Methods & Clinical Development

Cover Story Emerging From the Shadows: Lp(a) - American College of Cardiology

Frontiers Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care

Clinical Trial Design for Lipoprotein(a)-Lowering Therapies: JACC Focus Seminar 2/3 - ScienceDirect

Repeat Measures of Lipoprotein(a) Molar Concentration and Cardiovascular Risk

Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule